COMMUNIQUÉS West-GlobeNewswire
-
Communiqué de presse : Sanofi conclut un accord avec le gouvernement américain pour réduire le coût des médicaments et renforcer l’innovation
19/12/2025 -
Salarius Pharmaceuticals Announces Adjournment of Annual Meeting, Information for Reconvened Annual Meeting
19/12/2025 -
Tevogen CEO Donates Personal Shares to Support Local Fire Department
19/12/2025 -
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
19/12/2025 -
OncoInv and MaxBloch Partner to Expand Early Cancer Detection Across Central America
19/12/2025 -
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
19/12/2025 -
Cannabix Technologies Launches New Marijuana Breath Test Product Videos as U.S. Cannabis Reclassification Underscores the Urgent Need for Innovative Public Safety Solutions
19/12/2025 -
Bobby Rahal Automotive Group Donates $35,000 to SoldierStrong to Support Military Veterans in Taking Their Next Steps Forward
19/12/2025 -
European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor
19/12/2025 -
EMJX Enhances Gen2 Digital Asset Treasury Operating System On OpenAI’s Large Language Models (LLMs) for Research and Risk Decision Support
19/12/2025 -
Jyong Biotech Responds to Share Price and Volume Movement
19/12/2025 -
MIMEDX Announces Publication in the Journal of Inflammation Focused on Immunomodulatory Effects of Purion® Processed Human Amniotic Membrane Allografts In Vitro
19/12/2025 -
Remedy's Nutrition® Launches Mega VMT™ High-Potency Multivitamin to Revolutionize Daily Energy and Nutritional Wellness
19/12/2025 -
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
19/12/2025 -
Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
19/12/2025 -
Amplia Enters into Second Agreement with Korean Specialist Drug Screening Company Next&Bio to Explore Combination Therapy with FAK Inhibitor and kRAS Inhibitors
19/12/2025 -
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals
19/12/2025 -
Sienna Completes Acquisition in the Greater Toronto Area
19/12/2025 -
Polyrizon Submits Pre-Request for Designation to FDA for PL-16 Viral Blocker Designed to Reduce the Exposure to Influenza and Cold Viruses
19/12/2025
Pages